Matthew Davis reports tax withholding on shares at AQST
By AlphaYouPublished Form 4
Davis Matthew W.
Reporting filer
Matthew Davis reports tax withholding on shares, not an open-market purchase or sale, in Aquestive Therapeutics, Inc.. Form 4 filed Nov 12, 2026 lists 1 entry.
- Disclosed
- Nov 12, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Davis Matthew W. | 2026-11-10 | F | Tax/exercise withholding | 5303 | 3.52 | 94,697 | 2 days | Filed terms
|
Common Stock
- Owner
- Davis Matthew W.
- Date
- 2026-11-10
- Code
- F
- Action
- Tax/exercise withholding
- Quantity
- 5303
- Price
- 3.52
- Following holdings
- 94,697
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-10
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: F
- equity Swap Involved: false
- transaction Timeliness:
- transaction Shares: 5303
- id: F1
- transaction Price Per Share: 3.52
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 94697
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Davis Matthew W.: Chief Development Officer.
- F1: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.
Original sources
Prepared automatically from public filing data. Report a correction.